Press Releases
Reenal Doshi
ASA Urges FDA to Implement Good Manufacturing Principles for Vaporization Products - Americans for Safe Access
Washington, DC — In a letter to the heads of the U.S. Food & Drug Administration (FDA), the Centers for Disease Control and Prevention, and the U.S. Department of Health and Human Services, Americans for Safe Access calls for the safe regulation of vaporization products and cartridges. As part of its recommendations, ASA urges the FDA to use its regulatory authority to, at minimum, issue guidance that encourages consumers to only buy vaporization products in legal, licensed stores and not on the illicit market.
“The ongoing health crisis attributed to vaping highlights the need for regulations on issues such as third-party testing and accurate labeling,” said Heather Despres, Director of Americans for Safe Access’ Patient Focused Certification program. “For many medical cannabis patients, vaporization is a popular delivery method. Patients have a right to know what is in their medicine, and the FDA should recognize that the only way to prevent further health complications from vaping products is to allow a lawful, regulated marketplace for them to exist.”
Reenal Doshi
Americans for Safe Access Unveils Medical Cannabis Patient’s Guide for U.S. Travel - Americans for Safe Access
Washington, DC -- Americans for Safe Access (ASA) has released The Medical Cannabis Patient’s Guide for U.S. Travel in conjunction with the start of Labor Day weekend. This guide will help traveling patients understand the laws regarding access to cannabis in the states and territories that extend reciprocity to patients from other jurisdictions or permit the adult use of cannabis and will provide patients with a clear sense of how to obtain cannabis while traveling outside of their home jurisdictions. The guide also contains helpful tips for patients to bear in mind while traveling.
Reenal Doshi
DEA Announces Plan to Promulgate Regulations for the Approval of New Cannabis Cultivation Facility Licenses for Scientific Research - Americans for Safe Access
Washington, DC -- According to a press release by the U.S. Department of Justice on Monday, the Drug Enforcement Administration has filed a notice in the Federal Register of its intention to promulgate regulations that govern the growing of cannabis for scientific and medical research under DEA registration. This announcement comes just days before a court deadline to respond to a lawsuit by researchers--including Americans for Safe Access’ (ASA) longtime supporter Dr. Sue Sisley--and mounting bipartisan pressure from Congressional lawmakers to move forward on the applications that the DEA began collecting three years ago from prospective growers.
Reenal Doshi
ASA Unveils 2019 Report Cards for U.S. Medical Cannabis Programs - Americans for Safe Access
Washington, DC -- Americans for Safe Access (ASA) has released its 2019 report card titled, “2019 State of the States Report: An Analysis of Medical Cannabis Access in the United States” in conjunction with the start of the National Conference of State Legislatures (NCSL) Legislative Summit in Nashville, Tennessee.
The nearly 200-page report provides a detailed analysis of the state of medical cannabis programs in 47 states, the District of Columbia, and four territories on a ‘A’ to ‘F’ scale. States were assessed in six categories: 1) Patient rights and civil protections; 2) Access to medicine; 3) Ease of navigation; 4) Functionality; 5) Consumer safety and provider requirements; and 6) Medical cannabis as a tool in combating the opioid epidemic.
Reenal Doshi
Americans for Safe Access Partners with TheAnswerPage.com to Provide Continuing Medical Education (CME) Credits for Medical Professionals - Americans for Safe Access
W
ashington, DC -- Americans for Safe Access (ASA) announced today a partnership to provide continuing medical education (CME) credits for medical professionals through their Cannabis Care Certification (CCC) website. The CCC Comprehensive Medical Marijuana Curriculum, created by The Answer Page, Inc. (TAP), introduces the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions of cannabinoid-based medicines.
Reenal Doshi
Montana Laboratory Achieves National Certification - Americans for Safe Access
Olney, MT – Americans for Safe Access (ASA) is pleased to announce that Stillwater Laboratory of Olney, MT has been certified for laboratory analysis of cannabis products under ASA’s Patient Focused Certification (PFC) program and ISO/IEC 17025 through a dual accreditation program conducted with the American Association for Laboratory Accreditation (A2LA). PFC is a project of ASA and is the only nonprofit, third-party certification program for the cannabis industry based on quality standards issued by the American Herbal Products Association (AHPA) and the American Herbal Pharmacopoeia (AHP).
Reenal Doshi
Americans for Safe Access and Aurelius Data Join Forces to Create a Research Platform to Benefit Cannabis Patients - Americans for Safe Access
Washington, D.C. - Americans for Safe Access (ASA), the leading advocacy organization dedicated to ensuring safe and legal access to cannabis (marijuana) for therapeutic use and research, and Aurelius Data, Inc.(AD), the premier patient perception big data company, and announced a bold new partnership to gather and analyze millions of data points from cannabis patients.
Reenal Doshi
Americans for Safe Access Releases Patient’s Guide to CBD - Americans for Safe Access
Contact: Reenal Doshi, reenal@safeaccessnow.org, (202) 857-4272 x. 4
Washington, DC — Americans for Safe Access (ASA) has released the Patient’s Guide to CBD in response to the May 31 public hearing at the Federal Drug Administration (FDA) regarding products containing cannabis and cannabis-derived compounds. During the hearing, ASA was one of nearly 140 speakers chosen to formally present scientific information with slides and data about cannabis, cannabidiol (CBD), and other cannabis compounds at the hearing.
The Patient’s Guide to CBD is a comprehensive resource that covers a wide range of topics, including, available forms for use, what to look for on package labels, how to read a certificate of analysis, how CBD interacts with the endocannabinoid system, the current state of research, the compound’s legal status, and how to talk to one’s doctor about CBD.
Sean Khalepari
Americans for Safe Access Selected to Influence FDA Policy - Americans for Safe Access
Contact: Sean Khalepari | sean@safeaccessnow.org
Washington, DC — On May 31, 2019 the FDA will be holding a public hearing to collect scientific information and data on cannabis and cannabis derived products. In holding this hearing, the FDA is seeking public input on topics including health & safety risks, manufacturing & product quality, and marketing, labeling and sales. The FDA hearing on Products Containing Cannabis or Cannabis-Derived Compounds is scheduled from 7:00 AM - 6:00 PM.
David Mangone
Colorado Joins Americans for Safe Access End Pain, Not Lives Campaign - Americans for Safe Access
Contact: David Mangone | david@safeaccessnow.org
Law Passed Allowing Doctors to Recommend Cannabis Instead of Opioids
Washington, DC — Governor Jared Polis has signed into law SB-013, a bill that allows Colorado physicians to authorize individuals to use medical cannabis instead of opioids, including for acute pain. The bill also removes specific specialist requirements for physicians for minor patients and allows minor patients to consume non-smokable forms of cannabis on school grounds. The law will go into effect on August 2, 2019.
State Advocacy Resources
